Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -9 of 9 Show results per page	View Search Criteria \| Help With Results


1.		Phase I/II 5-Azacytidine Plus VPA Plus ATRA

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				3 and over				Other				2004-0799 NCT00326170


2.		Azacytidine With Valproic Acid Versus Ara-C in AML/MDS Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				60 and over				Other				2005-0177 NCT00382590


3.		PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Other				MDS0205 NCT00439673

Last Modified: 7/25/2008 First Published: 2/20/2004


4.		Phase I Study of Decitabine and Valproic Acid in Patients With Refractory or Relapsed Acute Myeloid Leukemia or With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				OSU-0336 NCI-6236, OSU-2003C0094, 6236, NCT00079378

Last Modified: 1/11/2007 First Published: 5/28/2004


5.		Phase I Study of Decitabine and Valproic Acid in Patients With Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				OSU-0346 OSU-2003C0087, NCI-6237, 6237, NCT00084981

Last Modified: 12/13/2007 First Published: 3/24/2005


6.		Phase I Study of Valproic Acid in Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				2 to 21				NCI				COG-ADVL0419 ADVL0419, NCI-05-C-0235, NCI-P6631, NCT00107458

Last Modified: 7/25/2008 First Published: 4/23/2005


7.		Phase I Study of Decitabine Alone or in Combination With Valproic Acid in Patients With Relapsed or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				OSU-2004C0119 6997, NCI-6997, OSU-0475, NCT00109824


8.		Azacytidine and Valproic Acid in Patients With Advanced Cancers

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				2 and over				Other				2004-0735 NCT00496444

Last Modified: 8/11/2008 First Published: 12/23/2003


9.		Pilot Study of Valproic Acid in Patients With Kaposi’s Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Completed				18 and over				NCI				AMC-038 NCT00075777

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute